NSG mice bearing subcutaneous BCMA+ human MM xenografts: dose-dependent anti-tumor activity and improved survival
“In mice bearing subcutaneous BCMA+ human MM xenografts, intravenous administration of bb2121 demonstrated dose-dependent anti-tumor activity and improved survival compared to control mice.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Why that model
Autologous human T cells do not engraft in immunocompetent animals, so immunodeficient xenograft mice were used
“No single or repeat-dose toxicity studies were conducted with ide-cel as traditional animal studies employing common toxicology study designs are not appropriate for ide-cel since autologous human T cells do not graft in immunocompetent animals.”
EMA: sufficient evidence of pharmacological activity and proof of concept in multiple myeloma
“Collectively, the pharmacological data provide sufficient evidence for pharmacological activity and a proof of concept for the use of ide-cel in the treatment of patients with multiple myeloma.”
autologous cultured chondrocytes on porcine collagen membrane · Autologous chondrocytes
Analogous MACI (animal cells on same membrane) in critical-sized knee/stifle cartilage defects in rabbits and horses: improved repair vs membrane alone or empty defect